Right.
I won't name the company, but I'll give you an example of a company. It's unlike drugs, where you're talking about $1 billion or more to get to market. Med-tech products typically are in the range of $10 million, $20 million, or $30 million to get to market. They're not at the same level.
A company I'm working with right now would have had probably about $500,000 to $1 million in research grants. They would have had about $1 million in government grants. They've levered that up with, currently, $3 million to $4 million in private sector funding, and they're doing another round of another $5 million after that. When they get to market, when a surgeon has actually bought the first product, they will have had about $15 million to $20 million of funding, of which probably $3 million would have been from government-related sources.
Those are very round numbers. Don't quote me on that, but it's—